Generic Drugs Market: Global Industry Trends, Manufacturing Process, Share, Size, Growth, Opportunity and Forecast 2017-2022
Copyright Š IMARC. All Rights Reserved
About IMARC Group
Report Description
IMARC is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Report Description and Highlights
Report Description
Global Generic Drugs Market Catalysed by Low Investments in R&D and Government Initiatives The global generic drugs market has witnessed a rapid growth in recent years. Some of the factors which have helped in the market growth of generic drugs are their performance characteristics, cost-effectiveness, reduced investments in R&D, patent expiry of the branded drugs, etc. The latest report by IMARC Group titled, “Generic Drugs Market: Global Industry Trends, Manufacturing Process, Share, Size, Growth, Opportunity and Forecast 2017-2022�, finds that the global generic drugs market reached a value of nearly US$ 230 Billion in 2016, growing at a CAGR of more than 7% during 2010-2016. Generic drugs have the same active ingredients and possess similar performance characteristics as their branded variants, such as strength, quality, form, effect, intended use, side effects, route of administration, therapeutic effect, etc. These drugs are manufactured under the same rules and regulations of manufacturing practices required for branded drugs. However, they are sold under their chemical names rather than the brand names. Read full report @ http://www.imarcgroup.com/generic-drug-manufacturing-plant
Report Description and Highlights
Report Description
Highlights of the global generic drugs market:
▪ The market is driven primarily by their affordability. ▪ The USA represents the largest market for these drugs, accounting for the majority of the share. ▪ The market is expected to reach a value of around US$ 360 Billion by 2022. The cost-effectiveness of the generic drugs has emerged as one of the major factors which has contributed in influencing the growth of the market. These drugs require low investments in research & development, which brings down the cost of manufacturing significantly. This has encouraged the government and third-party payers to promote the manufacturing of these drugs and save billions of dollars on healthcare expenditures. Apart from this, the patent expiry of the branded drugs is also an essential factor which provides encouragement to the generic drugs market. Most branded drugs come with a lifespan of 20 years during which other manufacturers cannot sell the branded drugs under their companies’ name. However, when the patent protection expires, the manufacturing rights of these drugs is available to the other manufacturers. Some of the other growth inducing factors include rising aging-population, increasing prevalence of chronic diseases, and incentives offered to physicians and pharmacists to promote generics. Further, the market is expected to reach a value of nearly US$ 360 Billion by 2022. Request Sample of the Report: http://www.imarcgroup.com/request?type=report&id=549&flag=B
Report Description and Highlights
Report Description
Report Description and Highlights
Report Description
The report has segmented the market on a regional basis. Some of the major markets for generic drugs include USA, China, Brazil, Germany and France. Amongst these, USA is the largest market, accounting for the majority of the share. An analysis of the competitive landscape provides the details of the key players operative in the market. Some of the major players are Teva Pharmaceuticals, Novartis–Sandoz, Mylan, Freseunis, and Hospira. The report has examined the global generic drugs market on the basis of: Key Regions: ▪ USA ▪ China ▪ Brazil ▪ Germany ▪ France Key Players: ▪ Teva Pharmaceuticals ▪ Novartis - Sandoz ▪ Mylan ▪ Freseunis ▪ Hospira
Report Description and Highlights
Report Description
Related Reports: Brazil Generic Drug Market @ http://www.imarcgroup.com/brazil-generic-drug-market US Generic Drug Market @ http://www.imarcgroup.com/us-generics-market
Report Description and Highlights
Report Description
Š 2017 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
Contact Us
FOR MORE DETAILS Visit us at :
http://www.imarcgroup.com Stay With Us:
TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com